Cleara Biotech

Utrecht, Netherlands · Founded 2018 · Privately Held (backing)

Operator of a biotechnology company intended to eliminate senescent cells to treat age-related pathologies. Cleara Biotech is based in Utrecht, Netherlands and was founded in 2018. It has raised $5 million.

Last price · $/share
—
Implied valuation
—
Total raised
$5.0M
Last round
—
Valuation — not yet established

No valuation for Cleara Biotech is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($5.0M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cleara Biotech with a free account
  • ·The complete investor list: 11 names
  • ·Watch Cleara Biotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Cleara Biotech funding history

No rounds on record

No funding rounds for Cleara Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Cleara Biotech's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Cleara Biotech, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Cleara Biotech

How much has Cleara Biotech raised?
Cleara Biotech has raised $5.0M in total funding across its recorded rounds.